Transient expression of PU.1 commits multipotent progenitors to a myeloid fate whereas continued expression favors macrophage over granulocyte differentiation.

OBJECTIVES The Ets-family transcription factor PU.1 is expressed specifically in the hematopoietic system, in which it is absolutely required for the generation of B lymphocytes and macrophages. In contrast, overexpression of PU.1 blocks terminal differentiation of the erythroid lineage, in which it can act as an oncogene. In this study we used a multipotential progenitor cell line to examine the effects of PU.1 overexpression on myeloerythroid commitment within a single model system. MATERIALS AND METHODS PU.1 cDNA was introduced transiently and stably into the multipotent, nonleukemic hemopoietic cell line FDCPmix. Transiently transfected cells were isolated by fluorescence-activated cell sorting within 18 hours of transfection. Stable transfectants were selected by antibiotic resistance over a number of weeks. The effects of short- and long-term overexpression of PU.1 on self-renewal, proliferation, and differentiation were investigated. RESULTS A transient pulse of expression in multipotent progenitor cells eliminated the options of self-renewal and erythroid differentiation, resulting in commitment to the myeloid lineage. However, this transient pulse of expression did not affect the subsequent lineage choice of bipotent granulocyte/macrophage progenitors. In contrast, continuous expression of PU.1 resulted in a strong bias toward macrophage rather than granulocyte differentiation. CONCLUSIONS These results demonstrate promyeloid effects of PU.1 at two distinct stages of hematopoiesis.

[1]  T. Graf,et al.  v‐Myb DNA binding is required to block thrombocytic differentiation of Myb‐Ets‐transformed multipotent haematopoietic progenitors. , 1995, The EMBO journal.

[2]  E. Scott,et al.  Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. , 1994, Science.

[3]  T. Graf,et al.  A functional Ets DNA-binding domain is required to maintain multipotency of hematopoietic progenitors transformed by Myb-Ets. , 1994, Genes & development.

[4]  K. Izuhara,et al.  PKCδ and ζ Mediate IL-4/IL-13-Induced Germline ϵ Transcription in Human B Cells: A Putative Regulation via PU.1 Phosphorylation , 2001 .

[5]  T. Shirai,et al.  Lineage switch induced by overexpression of Ets family transcription factor PU.1 in murine erythroleukemia cells. , 2001, Blood.

[6]  M. Klemsz,et al.  Hematopoietic lineage- and stage-restricted expression of the ETS oncogene family member PU.1. , 1993, Blood.

[7]  A. Feeney,et al.  Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. , 1996, The EMBO journal.

[8]  T. Dexter,et al.  The role of hemopoietic growth factors in self-renewal and differentiation of IL-3-dependent multipotential stem cells. , 1990, Growth factors.

[9]  T. Schroeder,et al.  Notch signalling via RBP‐J promotes myeloid differentiation , 2000, The EMBO journal.

[10]  B. Calabretta,et al.  Granulocytic differentiation of normal hematopoietic precursor cells induced by transcription factor PU.1 correlates with negative regulation of the c-myb promoter. , 1997, Blood.

[11]  D. Tenen,et al.  PU.1 (Spi-1) and C/EBP alpha regulate expression of the granulocyte-macrophage colony-stimulating factor receptor alpha gene , 1995, Molecular and cellular biology.

[12]  D. Tenen,et al.  PU.1 (Spi-1) and C/EBP alpha regulate the granulocyte colony-stimulating factor receptor promoter in myeloid cells. , 1996, Blood.

[13]  T. Graf,et al.  PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. , 1998, Genes & development.

[14]  J. Walsh,et al.  PU.1 regulates both cytokine‐dependent proliferation and differentiation of granulocyte/macrophage progenitors , 1998, The EMBO journal.

[15]  H. Fiegler,et al.  A transient assay for regulatory gene function in haemopoietic progenitor cells , 2000, British journal of haematology.

[16]  C. J. Barnett,et al.  Opposing actions of c-ets/PU.1 and c-myb protooncogene products in regulating the macrophage-specific promoters of the human and mouse colony-stimulating factor-1 receptor (c-fms) genes , 1994, The Journal of experimental medicine.

[17]  D. Tenen,et al.  The macrophage transcription factor PU.1 directs tissue-specific expression of the macrophage colony-stimulating factor receptor , 1993, Molecular and cellular biology.

[18]  T. Enver,et al.  GATA‐2 and GATA‐2/ER display opposing activities in the development and differentiation of blood progenitors , 2002, The EMBO journal.

[19]  Midori Yoshida,et al.  Overexpression of PU.1 induces growth and differentiation inhibition and apoptotic cell death in murine erythroleukemia cells. , 1997, Blood.

[20]  G. Cheng,et al.  Deregulated expression of the PU.1 transcription factor blocks murine erythroleukemia cell terminal differentiation , 1997, Oncogene.

[21]  H. Singh,et al.  Regulation of B lymphocyte and macrophage development by graded expression of PU.1. , 2000, Science.

[22]  W. Ostertag,et al.  Transcriptional regulation of the c-fms proto-oncogene mediated by granulocyte/macrophage colony-stimulating factor (GM-CSF) in murine cell lines. , 1996, Oncogene.

[23]  T. Dexter,et al.  Self-renewal and differentiation of interleukin-3-dependent multipotent stem cells are modulated by stromal cells and serum factors. , 1986, Differentiation; research in biological diversity.

[24]  J. Pierce,et al.  Induction of the granulocyte-macrophage colony-stimulating factor (CSF) receptor by granulocyte CSF increases the differentiative options of a murine hematopoietic progenitor cell , 1990, Molecular and cellular biology.

[25]  E. Scott,et al.  C/EBP Bypasses Granulocyte Colony-Stimulating Factor Signals to Rapidly Induce PU.1 Gene Expression, Stimulate Granulocytic Differentiation, and Limit Proliferation in 32D cl3 Myeloblasts , 1999 .

[26]  N. Nicola,et al.  Subunit promiscuity among hemopoietic growth factor receptors , 1991, Cell.

[27]  Johann Meyer,et al.  Host cis-Mediated Extinction of a Retrovirus Permissive for Expression in Embryonal Stem Cells during Differentiation , 1998, Journal of Virology.

[28]  T. Dexter,et al.  Erythroid development of the FDCP‐Mix A4 multipotent cell line is governed by the relative concentrations of erythropoietin and interleukin 3 , 1995, British journal of haematology.